Dickson Catherine, Taljaard Monica, Friedman Dara Spatz, Metz Gila, Wong Tom, Grimshaw Jeremy M
Medical Resident,School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Alta Vista Campus Room, Ottawa, Canada.
Department of Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Civic Campus, Ottawa, Canada.
Sex Transm Infect. 2017 Dec;93(8):561-565. doi: 10.1136/sextrans-2017-053224. Epub 2017 Aug 26.
This study assessed adherence with first-line gonorrhoea treatment recommendations in Ontario, Canada, following recent guideline changes due to antibiotic resistance.
We used interrupted times-series analyses to analyse treatment data for cases of uncomplicated gonorrhoea reported in Ontario, Canada, between January 2006 and May 2014. We assessed adherence with first-line treatment according to the guidelines in place at the time and the use of specific antibiotics over time. We used the introduction of new recommendations in the in 2008 and 2011 and the release of the province of Ontario's in 2013 as interruptions in the time-series analysis.
Overall, 34 287 gonorrhoea cases were reported between 1 January 2006 and 31 May 2014. Treatment data were available for 32 312 (94.2%). Our analysis included 32 272 (94.1%) cases without either a conjunctival or disseminated infection. Following the release of the 2011 recommendations, adherence with first-line recommendations immediately decreased to below 30%. Adherence slowly increased but did not reach baseline levels before the 2013 guidelines were released. Following release of the 2013 guidelines, adherence again decreased; adherence is slowly recovering but by May 2014, was only approximately 60%.
Due to concerns about antibiotic resistance, gonorrhoea treatment guidelines need to be updated regularly and rapidly adopted in practice. Our study showed poor adherence following dissemination of updated guidelines. Over a year after the latest Ontario guidelines were released, 40% of patients did not receive first-line treatment, putting them at risk of treatment failure and potentially promoting further drug resistance. Greater attention should be devoted to dissemination and implementation of new guidelines.
本研究评估了加拿大安大略省在因抗生素耐药性导致近期指南变更后,对一线淋病治疗建议的遵循情况。
我们采用中断时间序列分析,对2006年1月至2014年5月间加拿大安大略省报告的非复杂性淋病病例的治疗数据进行分析。我们根据当时有效的指南评估对一线治疗的遵循情况以及特定抗生素随时间的使用情况。我们将2008年和2011年新建议的引入以及安大略省2013年发布的[具体内容未提及]作为时间序列分析中的中断点。
总体而言,2006年1月1日至2014年5月31日期间共报告了34287例淋病病例。有32312例(94.2%)可获得治疗数据。我们的分析纳入了32272例(94.1%)既无结膜感染也无播散性感染的病例。2011年建议发布后,对一线建议的遵循率立即降至30%以下。遵循率缓慢上升,但在2013年指南发布前未达到基线水平。2013年指南发布后,遵循率再次下降;遵循率正在缓慢恢复,但到2014年5月,仅约为60%。
由于对抗生素耐药性的担忧,淋病治疗指南需要定期更新并在实践中迅速采用。我们的研究表明,更新后的指南发布后遵循情况不佳。在安大略省最新指南发布一年多后,40%的患者未接受一线治疗,使他们面临治疗失败的风险,并可能进一步促进耐药性。应更加关注新指南的传播和实施。